新型生物标志物在肾小球疾病中不断演变的作用:综述
本文综述了肾小球疾病血清学评估的最新进展,重点讨论原发性膜性肾病中磷脂酶A2受体、THSD7A及NELL-1等自身抗体,以及C3肾小球病和纤维样肾小球肾炎的新型生物标志物。这些标志物可提高诊断敏感性、动态监测疾病活动并捕捉遗传异质性,补充肾活检的组织学模式。
要点
- 膜性肾病自身抗体谱扩展至PLA2R、THSD7A和NELL-1,血清学评估更精细。
- C3肾小球病和纤维样肾小球肾炎的新型标志物可辅助肾活检组织学诊断。
- 验证过的生物标志物能提高敏感性、纵向监测活动性并反映遗传异质性。
核心结论
- 验证过的肾小球生物标志物通过提高敏感性、允许动态纵向监测疾病活动性和捕捉遗传异质性,显著补充诊断与治疗决策。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 原发性膜性肾病循环自身抗体包括磷脂酶A2受体、THSD7A及NELL-1。
- C3肾小球病和纤维样肾小球肾炎的新型生物标志物可补充传统肾活检组织学模式。
- 肾活检仍是肾小球疾病分型的金标准,但新型标志物可改善诊断与治疗路径。
临床怎么用
- 肾内科医生可依据血清自身抗体谱对膜性肾病进行更精细评估。
- 在C3肾小球病和纤维样肾小球肾炎中,可考虑用新型生物标志物辅助肾活检组织学诊断。
- 利用验证过的标志物纵向监测疾病活动性,并捕捉遗传异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent advances in glomerular biology have expanded our understanding of glomerular diseases, leading to more precise therapeutic options. Since the discovery of the autoantigen phospholipase A2 receptor in primary membranous nephropathy 10 years ago, the serologic evaluation of glomerular diseases has become more detailed and nuanced for nephrologists. In addition to phospholipase A2 receptor antibodies, circulating autoantibodies now include thrombospondin type 1 domain-containing 7A and most recently, neural epidermal growth factor-like 1 protein for membranous nephropathy. Additionally, discoveries in C3 glomerulopathy and fibrillary glomerulonephritis are poised to improve the diagnostic approach to these disorders by using novel biomarkers to complement traditional histologic patterns on kidney biopsy. Although kidney biopsies are considered the gold standard in profiling glomerular diseases, validated novel glomerular biomarkers contribute substantially to the diagnostic and therapeutic approaches through their ability to improve sensitivity, permit dynamic longitudinal monitoring of disease activity, and capture genetic heterogeneity. We describe the value of specific biomarkers in selected glomerular diseases, with the major focus on their clinical applicability.
引用
- Cavanaugh C, Okusa MD. The Evolving Role of Novel Biomarkers in Glomerular Disease: A Review. Am J Kidney Dis. 2020. PMID: 33077315. doi:10.1053/j.ajkd.2020.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。